Biography
Toykan leads operations and customer success at Massive Bio, building robust processes and dedicated support systems that ensure patients and partners receive exceptional service throughout their journey. He is passionate about removing friction points in the patient experience and fostering long-term relationships with healthcare providers. He drives operational excellence while keeping patient outcomes at the center of every decision. He is a member of the European Society for Medical Oncology (ESMO) and the European Hematology Association (EHA).
Understanding the Different Types of Myelofibrosis: Primary vs. Secondary
AUGUST 2025
Understanding the Latest Stage 4 Lung Cancer Survival Statistics
AUGUST 2025
What Causes Multiple Myeloma? Exploring Genetic and Environmental Factors
JUNE 2025
Breast Cancer Risk Factors You Should Know
MAY 2025
Why Cervical Cancer Rates Are Rising in Young Women
FEBRUARY 2025
Bone Marrow Cancer Facts: What Every Patient Needs to Know First
FEBRUARY 2025
Understanding Limited Stage Small Cell Lung Cancer
FEBRUARY 2025
Paclitaxel Chemotherapy: Side Effects, Success Rates & Safety Guidelines
JANUARY 2025
Understanding Tumor Lymph Nodes in the Neck
DECEMBER 2024
ICD-10 Codes for Bladder Cancer: Complete Guide to Classification and Diagnosis
NOVEMBER 2024
Urothelial Cancer
SEPTEMBER 2024
What Are The First Signs of Metastatic Breast Cancer?
AUGUST 2024
Myelofibrosis and Myelodysplastic Syndrome
JUNE 2024
Lung cancer ICD 10
JUNE 2024
Stage 4 Esophageal Cancer
MAY 2024
Vulvar Melanoma
MAY 2024
High Hemoglobin
MAY 2024
Amelanotic Melanoma
APRIL 2024
Early Stage Skin Cancer
APRIL 2024
Benign Melanoma
APRIL 2024
Lung Cancer Prognosis
MARCH 2024
Is Low Potassium a Sign Of Cancer
JANUARY 2024
What’s New in MCL Clinical Trials?
OCTOBER 2023
What to know about mantle cell lymphoma?
OCTOBER 2023